LifeMD, Inc. (NASDAQ:LFMDP) Short Interest Update

LifeMD, Inc. (NASDAQ:LFMDPGet Free Report) was the recipient of a large growth in short interest during the month of October. As of October 15th, there was short interest totalling 300 shares, a growth of 200.0% from the September 30th total of 100 shares. Based on an average daily volume of 2,100 shares, the days-to-cover ratio is currently 0.1 days.

LifeMD Price Performance

Shares of LifeMD stock remained flat at $22.23 on Friday. The stock had a trading volume of 8 shares, compared to its average volume of 7,172. The firm’s 50 day moving average is $22.17 and its 200-day moving average is $22.19. LifeMD has a one year low of $17.15 and a one year high of $25.00.

LifeMD Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, October 15th. Stockholders of record on Friday, October 4th were paid a dividend of $0.5547 per share. The ex-dividend date was Friday, October 4th. This represents a $2.22 annualized dividend and a dividend yield of 9.98%.

LifeMD Company Profile

(Get Free Report)

LifeMD, Inc operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States. The company offers telehealth platform comprising RexMD, a men's telehealth brand that provides access to virtual medical treatment for a variety of men's health needs from licensed physician; ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss; NavaMD, a female-oriented tele-dermatology that offers virtual medical treatment from dermatologists and other providers; and prescription oral and compounded topical medications to treat aging and acne; and Cleared which provides personalized treatments for allergy, asthma and immunology, including in-home tests for both environmental and food allergies, prescriptions for allergies and asthma and immunotherapies for treating chronic allergies.

See Also

Receive News & Ratings for LifeMD Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeMD and related companies with MarketBeat.com's FREE daily email newsletter.